Northwest Biotherapeutics | NWBO - Fremdkapital





Fremdkapital Veränderung Datum
Agenus USD 169.66M 146.06M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eisai JPY 134.77B 12M 2025-12
Infinity Pharmaceuticals USD 0 0 2022-06
Merck USD 39.97B 6B 2025-09
Northwest Biotherapeutics USD 31.8M 11.49M 2025-09
Pfizer USD 57.41B 93M 2025-09
Plus Therapeutics USD 3.79M 322K 2022-12
Roche Holding CHF 27.43B 966M 2025-12